Coloplast A/S (OTCMKTS:CLPBY) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) posted its earnings results on Tuesday. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01, Zacks reports. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.

Coloplast A/S Price Performance

Shares of OTCMKTS CLPBY opened at $6.29 on Thursday. Coloplast A/S has a twelve month low of $6.10 and a twelve month high of $10.03. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. The firm has a 50-day moving average of $6.71 and a two-hundred day moving average of $7.96. The company has a market capitalization of $14.17 billion, a price-to-earnings ratio of 44.93, a PEG ratio of 2.07 and a beta of 0.15.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CLPBY. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Coloplast A/S has a consensus rating of “Reduce”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.